
Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 25
2026-05-12 10:35:03Surging to a fresh 52-week high of Rs 25 on 12 May 2026, Nexus Surgical and Medicare Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a bearish backdrop for the Sensex.
Read full news article
Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 24.51
2026-05-11 13:35:03With a 62.97% gain over the past year, Nexus Surgical and Medicare Ltd surged to a fresh 52-week high of Rs 24.51 on 11 May 2026, outpacing the Sensex which declined 3.74% over the same period. This milestone caps a five-day winning streak that has propelled the stock 35.04% higher, underscoring a powerful momentum shift despite a broadly weaker market backdrop.
Read full news article
Nexus Surgical and Medicare Ltd Upgraded to Sell Amid Mixed Technicals and Valuation Concerns
2026-04-02 08:05:02Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, driven primarily by changes in its technical outlook despite persistent fundamental challenges. The micro-cap NBFC’s technical indicators have shifted from mildly bullish to sideways, prompting a reassessment of its near-term prospects amid flat financial performance and valuation concerns.
Read full news article
Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns
2026-03-26 08:03:35Nexus Surgical and Medicare Ltd, a micro-cap player in the Non-Banking Financial Company (NBFC) sector, has been downgraded from a Sell to a Strong Sell rating as of 25 March 2026. The revision reflects a deterioration in technical indicators, valuation concerns, and a flat financial trend, despite the company’s historically strong returns over the long term. This comprehensive analysis explores the four key parameters that triggered the rating change: Quality, Valuation, Financial Trend, and Technicals.
Read full news article
Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements
2026-03-09 08:02:54Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 March 2026, driven primarily by improvements in technical indicators despite persistent valuation and financial trend challenges. The company’s technical outlook has shifted to mildly bullish, prompting a reassessment of its near-term prospects, although fundamental concerns remain.
Read full news article
Nexus Surgical and Medicare Ltd Forms Golden Cross, Signalling Potential Bullish Breakout
2026-03-06 18:55:06Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has recently formed a Golden Cross—a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often heralds a bullish breakout, signalling a potential long-term momentum shift and trend reversal for the stock.
Read full news article
Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns
2026-02-26 08:02:20Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 25 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality scores, signalling caution for investors amid a challenging market environment.
Read full news article
Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements and Valuation Insights
2026-02-23 08:03:45Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Feb 2026, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this upgrade, the company continues to face valuation and fundamental challenges, with flat recent financial performance and a high price-to-book ratio. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change and what it means for investors.
Read full news articleReply On Clarification Sought By Exchange
13-May-2026 | Source : BSEReply on Clarification sought by the Exchange on Price Movement of the Script of the Company
Clarification sought from Nexus Surgical And Medicare Ltd
12-May-2026 | Source : BSEThe Exchange has sought clarification from Nexus Surgical And Medicare Ltd on May 12 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Apr-2026 | Source : BSESubmission of Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






